Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693286018 | Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693288017 | Framycetin sulfate 5 mg/g eye ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product containing framycetin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Ophthalmic anti-infective preparation | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Topical neomycin | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Skin anti-infective | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Framycetin | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has manufactured dose form | Eye ointment | true | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product containing neomycin in ophthalmic dosage form | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product containing framycetin in ocular dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength numerator value | 5 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has basis of strength substance (attribute) | Framycetin sulfate | true | Inferred relationship | Some | 1 | |
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has precise active ingredient | Framycetin sulfate | true | Inferred relationship | Some | 1 | |
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Framycetin only product in ocular dose form | true | Inferred relationship | Some | ||
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR